ApoB vs LDL-C
ApoB counts every atherogenic particle (LDL, VLDL, IDL, Lp(a)). LDL-C estimates cholesterol mass inside LDL particles. When the two diverge — common in metabolic syndrome and insulin resistance — ApoB is the more accurate cardiovascular risk marker.
ApoB is the preferred decisional marker for cardiovascular optimization, especially with metabolic syndrome, insulin resistance, or discordant lipids.
LDL-C remains useful as a trend marker and for continuity with historical labs.
Educational. Final pathway selection is provider-reviewed via synchronous video consultation against your biomarkers, history, and goals.
Frequently asked
If LDL-C is normal, do I still need ApoB?
Yes — discordance between LDL-C and ApoB is common and only ApoB resolves it.
Is ApoB on the standard panel?
It is included in the extended lipid panel reviewed during cardiovascular-anchored optimization.
Take the optimization assessment.
The adaptive assessment maps your symptoms, history, and goals to candidate pathways — and routes you into provider review.
Begin assessment